MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Use with caution

Mirapexin 2.1mg modified-release tablets (Boehringer Ingelheim Ltd)

Explore other Pramipexole formulations Explore other Pramipexole 2.1mg modified-release tablets suppliers

Stability Notes

Protect from moisture. Max 14 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 2.1mg modified-release tablets (Boehringer Ingelheim Ltd).

Use with caution

Mirapexin 2.1mg modified-release tablets (CST Pharma Ltd)

Explore other Pramipexole formulations Explore other Pramipexole 2.1mg modified-release tablets suppliers

Stability Notes

Protect from moisture. Max 14 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 2.1mg modified-release tablets (Boehringer Ingelheim Ltd).

Use with caution

Mirapexin 2.1mg modified-release tablets (Sigma Pharmaceuticals Plc)

Explore other Pramipexole formulations Explore other Pramipexole 2.1mg modified-release tablets suppliers

Stability Notes

Protect from moisture. Max 14 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 2.1mg modified-release tablets (Boehringer Ingelheim Ltd).

Use with caution

Mirapexin 2.62mg modified-release tablets (Boehringer Ingelheim Ltd)

Explore other Pramipexole formulations Explore other Pramipexole 2.62mg modified-release tablets suppliers

Stability Notes

Protect from moisture. Max 14 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 2.62mg modified-release tablets (Boehringer Ingelheim Ltd).

Use with caution

Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd)

Explore other Pramipexole formulations Explore other Pramipexole 3.15mg modified-release tablets suppliers

Stability Notes

Protect from moisture. Max 14 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd).

Use with caution

Mirapexin 3.15mg modified-release tablets (CST Pharma Ltd)

Explore other Pramipexole formulations Explore other Pramipexole 3.15mg modified-release tablets suppliers

Stability Notes

Protect from moisture. Max 14 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd).

Use with caution

Mirapexin 3.15mg modified-release tablets (Sigma Pharmaceuticals Plc)

Explore other Pramipexole formulations Explore other Pramipexole 3.15mg modified-release tablets suppliers

Stability Notes

Protect from moisture. Max 14 days in an MCA.

Provenance

This compatibility recommendation is derived from Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd).

No Stability Information

Mirena 20micrograms/24hours intrauterine device (Bayer Plc)

Explore other Levonorgestrel formulations Explore other Levonorgestrel 20micrograms/24hours intrauterine device suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Mirena 20micrograms/24hours intrauterine device (CST Pharma Ltd)

Explore other Levonorgestrel formulations Explore other Levonorgestrel 20micrograms/24hours intrauterine device suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Mirena 20micrograms/24hours intrauterine device (Pharmaram Ltd)

Explore other Levonorgestrel formulations Explore other Levonorgestrel 20micrograms/24hours intrauterine device suppliers

Stability Notes

There are no stability notes available for this medicine.

Incompatible

Mirtazapine 15mg orodispersible tablets (A A H Pharmaceuticals Ltd)

Explore other Mirtazapine formulations Explore other Mirtazapine 15mg orodispersible tablets suppliers

Stability Notes

Orodispersible tablet.

Provenance

Compatibility recommendation derived from Mirtazapine 15mg orodispersible tablets (Accord HealthCare Ltd).

Incompatible

Mirtazapine 15mg orodispersible tablets (Accord-UK Ltd)

Explore other Mirtazapine formulations Explore other Mirtazapine 15mg orodispersible tablets suppliers

Stability Notes

Orodispersible tablet.

Provenance

Compatibility recommendation derived from Mirtazapine 15mg orodispersible tablets (Accord HealthCare Ltd).

Incompatible

Mirtazapine 15mg orodispersible tablets (Alliance Healthcare (Distribution) Ltd)

Explore other Mirtazapine formulations Explore other Mirtazapine 15mg orodispersible tablets suppliers

Stability Notes

Orodispersible tablet.

Provenance

Compatibility recommendation derived from Mirtazapine 15mg orodispersible tablets (Accord HealthCare Ltd).

Incompatible

Mirtazapine 15mg orodispersible tablets (Almus Pharmaceuticals Ltd)

Explore other Mirtazapine formulations Explore other Mirtazapine 15mg orodispersible tablets suppliers

Stability Notes

Orodispersible tablet.

Provenance

Compatibility recommendation derived from Mirtazapine 15mg orodispersible tablets (Accord HealthCare Ltd).

Incompatible

Mirtazapine 15mg orodispersible tablets (Medihealth (Northern) Ltd)

Explore other Mirtazapine formulations Explore other Mirtazapine 15mg orodispersible tablets suppliers

Stability Notes

Orodispersible tablet.

Provenance

Compatibility recommendation derived from Mirtazapine 15mg orodispersible tablets (Accord HealthCare Ltd).

Print this list

Compatible

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.

Use with caution

Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.

Incompatible

Medicines under this category are not suitable for use inside MCAs.

No Stability Information

We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.